Healthy Living After Knee Replacement

May 11, 2023 updated by: Christine A Pellegrini, PhD, University of South Carolina

Physical Activity and Weight Loss to Improve Function and Pain After Total Knee Replacement

The purpose of this study is to examine if a weight loss program designed for adults after knee replacement improves weight loss, physical activity, pain, and function, as well as if the program is cost effective, as compared to a chronic disease self-management program.

Study Overview

Detailed Description

Participants will be randomized to either a weight loss program or chronic disease self-management program. Both programs will be phone-based and include phone calls with a health coach weekly during months 1-4, biweekly during months 5-6, and monthly during months 7-12. Monthly calls with occur between months 13-18. Assessments examining outcomes will be completed at baseline, 6, 12, and 18 months.

Study Type

Interventional

Enrollment (Anticipated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • South Carolina
      • Columbia, South Carolina, United States, 29208
        • Recruiting
        • University of South Carolina
        • Contact:
        • Principal Investigator:
          • Christine Pellegrini, Ph.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Participants must:

  • have a body mass index between 25-45 kg/m2
  • have had a knee replacement (including primary, staged or independent bilateral, or revision) <6 months prior to baseline assessment
  • have a computer, tablet, or smartphone with active internet access to self-monitor online and/or have a device or computer compatible with Fitbit
  • completion of baseline assessment measures (height, weight, function tests, surveys, ≥4 days valid of activity monitoring, and 1 day of dietary recall)
  • be English-speaking and able to read consent and study materials written in English
  • be willing to attend 4 in-person assessments.

Exclusion Criteria:

  • have any contraindications to diet or weight loss
  • undergo simultaneous bilateral knee replacement or have a scheduled or anticipated knee replacement for the contralateral knee within the next 18 months
  • have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinal stenosis, fibromyalgia, peripheral vascular disease, stroke)
  • are taking anti-obesity medications
  • are enrolled in a formal weight loss program
  • had or are planning to have bariatric/gastric/lap band surgery
  • are planning to relocate out of the Columbia or Greenville, SC areas in the next 18 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PACE Weight Loss Program
Participants randomized to this arm will receive personalized diet, activity, and weight loss goals as well as tools to self-monitor behaviors and weight. To facilitate changes, participants will receive coaching calls weekly during months 1-4, biweekly during months 5-6, and monthly during months 7-12.
12 month phone-based behavioral weight loss program
Sham Comparator: Chronic Disease Self-Management Program
Participants randomized to this arm will receive a chronic disease self-management program including a self-management book. Participants will receive regular calls weekly during months 1-4, biweekly during months 5-6, and monthly during months 7-12.
12 month phone-based chronic disease self-management program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in body weight at 6 months
Time Frame: 6 months
kg
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in WOMAC pain subscale at 6 months
Time Frame: 6 months
WOMAC Pain Subscale - Scores range from 0 (no pain) to 20 (maximal pain)
6 months
Change in WOMAC pain subscale at 12 months
Time Frame: 12 months
WOMAC Pain Subscale - Scores range from 0 (no pain) to 20 (maximal pain)
12 months
Change in WOMAC pain subscale at 18 months
Time Frame: 18 months
WOMAC Pain Subscale - Scores range from 0 (no pain) to 20 (maximal pain)
18 months
Change in Six Minute Walk Duration at 6 months
Time Frame: 6 months
Physical function assessed with the six minute walk test (feet)
6 months
Change in Six Minute Walk Duration at 12 months
Time Frame: 12 months
Physical function assessed with the six minute walk test (feet)
12 months
Change in Six Minute Walk Duration at 18 months
Time Frame: 18 months
Physical function assessed with the six minute walk test (feet)
18 months
Change in Timed Up & Go at 6 months
Time Frame: 6 months
Physical function assessed with the Timed Up & Go Test (seconds)
6 months
Change in Timed Up & Go at 12 months
Time Frame: 12 months
Physical function assessed with the Timed Up & Go Test (seconds)
12 months
Change in Timed Up & Go at 18 months
Time Frame: 18 months
Physical function assessed with the Timed Up & Go Test (seconds)
18 months
Change in Chair Stands at 6 months
Time Frame: 6 months
Physical function assessed with the Chair stand test (# of chair stands)
6 months
Change in Chair Stands at 12 months
Time Frame: 12 months
Physical function assessed with the Chair stand test (# of chair stands)
12 months
Change in Chair Stands at 18 months
Time Frame: 18 months
Physical function assessed with the Chair stand test (# of chair stands)
18 months
Change in Moderate to vigorous intensity physical activity at 6 months
Time Frame: 6 months
Objectively measured by Actigraph accelerometer (>=2020 counts/min)
6 months
Change in Moderate to vigorous intensity physical activity at 12 months
Time Frame: 12 months
Objectively measured by Actigraph accelerometer (>=2020 counts/min)
12 months
Change in Moderate to vigorous intensity physical activity at 18 months
Time Frame: 18 months
Objectively measured by Actigraph accelerometer (>=2020 counts/min)
18 months
Change in body weight at 12 months
Time Frame: 12 months
kg
12 months
Change in body weight at 18 months
Time Frame: 18 months
kg
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christine Pellegrini, PhD, University of South Carolina

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 4, 2022

Primary Completion (Anticipated)

August 30, 2025

Study Completion (Anticipated)

June 30, 2026

Study Registration Dates

First Submitted

December 28, 2021

First Submitted That Met QC Criteria

January 12, 2022

First Posted (Actual)

January 13, 2022

Study Record Updates

Last Update Posted (Actual)

May 12, 2023

Last Update Submitted That Met QC Criteria

May 11, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pro00109459
  • R01AG070004 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We will also make de-identified study data available 12 months after the primary manuscript is published.

IPD Sharing Time Frame

12 months after primary manuscript is published

IPD Sharing Access Criteria

Open

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthroplasty

Clinical Trials on PACE Weight Loss program

3
Subscribe